1
2
2020年12月7日,-White blood cells are part of many immune system responses in the human body. New research shows that a specific type of those cells may cause brain cancer tissues to die -- but that's not good ...
Jan. 20, 2022 —Studies since the start of the pandemic have noted that pigs exposed to the coronavirus don't show clinical signs of disease nor do they transmit the virus to other animals. Scientists have ...
July 31, 2023 —Scientists have identified a protein that plays a pivotal role in the action of several emerging cancer therapies. The researchers say the discovery will likely aid efforts to fine-tune the use of ...
June 17, 2021 —Inhibiting necroptosis, a form of cell death, could yield a new treatment approach for chronic obstructive pulmonary disease (COPD), an inflammatory lung condition also known as emphysema, new ...
Feb. 18, 2022 —A pathway critical for regulating a form of cell death known as necroptosis has been identified. The team's preclinical findings suggest that an inhibitor targeting this PPP13RG protein complex ...
Aug. 17, 2020 —Scientists have discovered a previously unknown method used by bacteria to evade immune ...
Jan. 13, 2022 —Understanding the basic mechanisms that lead to cell death (apoptosis) is essential for the development of therapies for cancer and other diseases. Scientists have now discovered a protein ...
Aug. 1, 2022 —All human tumors originating from various tissues share a series of properties that define them, including the ability to prevent cell death. Instead, healthy organs induce programmed cell death or ...
July 11, 2022 —Inducing programmed cell death (PCD), such as apoptosis, is a widely used therapeutic option for the treatment of cancer. Unfortunately, many cancer cells become resistant to PCDs, and continue ...
Aug. 5, 2021 —A gene called DOT1L appears to play a role in progression and severity of ovarian cancer, and inhibitors of the DOT1L enzyme may offer a new therapeutic approach for the disease, researchers say in a ...